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ABSTRACT 
Inflammation is one of the innate defence mechanisms exerted by the human body for protection 
and to initiate the healing process. Chronic inflammatory reactions can lead to several disease 
conditions like asthma, allergic rhinitis and rheumatoid arthritis. A central role in these diseases is 
played by the Leukotriene (LT) family of the lipid mediators, one of family of pro-inflammatory 
lipid mediators derived from the 20-carbon fatty acid arachidonic acid. The key enzyme involved 
in LT biosynthesis is 5-Lipoxygenase (5LO) which initiates the leukotriene biosynthesis by 
catalysing the conversion of arachidonic acid (AA) to leukotriene A4 (LTA4). In this thesis, one 
aim is to elucidate the interactions of 5LO with the membrane and components therein which is 
the first step in the leukotriene biosynthesis and which could be one possible drug target. 
Furthermore, details of the LTA4 formation were investigated as well as LTA4 hydrolysis. 
In Paper I & II, we demonstrated the calcium-mediated binding of 5LO with membranes in vitro 
using a membrane substitute called nanodisc. The selected nanodisc platform contained 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and the membrane scaffolding protein 
MSP1E3D1 which provides a bilayer surface of inner diameter around 10 nm. Paper I shows 
5LO binds directly with nanodiscs in the presence of calcium. This calcium-mediated binding 
was shown by non-denaturing gel-electrophoresis. Due to the high binding affinity, the 5LO-
nanodisc complex was visible in the gel in the absence of calcium ions during the gel run. In the 
presence of Ca2+, a titration varying the ratio of 5LO to nanodiscs showed that maximum two 
5LO binds to the nanodiscs used. The binding of 5LO with nanodiscs in the presence of calcium 
aides in the product formation and the results are comparable with the similar membrane mimic, 
liposomes. The complex of 5LO with nanodiscs was visualized for the first time by non-
denaturing gel-electrophoresis and negative stain transmission electron microscopy (TEM). 
Furthermore, our results indicated that a 5LO dimer can be formed and it is formed by 
intermolecular disulphide bonds between cysteines located on the protein surface. The dimeric 
5LO does not bind to a membrane and has no enzymatic activity. We have visualized also the 
dimer of 5LO by TEM. This paper clearly demonstrates the advantages of the application of 
nanodiscs as a membrane substitute to study monotopic membrane proteins. Paper II specifically 
focuses on a method developed to directly visualize and optimize conditions for the interaction of 
peripheral membrane proteins with the membrane using TEM. This method utilizes the 
phenomenon of stacking of phospholipids by a negative stain called sodium phosphotungstic acid 
(NaPT). Nanodiscs were used as a membrane substitute and form long stacks when stained with 
NaPT. The absence of stacking can be interpreted as a positive interaction between a protein and 
membrane, i.e. the protein bound to the nanodisc membrane prevents it from being stacked by the 
NaPT. With the help of this method, we have visualized different binding modes of 5LO with the 
membrane. 
Paper III unravels the mechanism of product formation of 5LO by kinetic isotope effect. The 
results shed light on regiospecificity, H-transfer and donor-acceptor regulations in the 
oxygenation of AA. 
Paper IV deciphers the secret behind dual product formation and reduced suicidal inactivation of 
Xenopus laevis (African clawed toad) leukotriene A4 hydrolase, xlLTA4H, by solving the 
structure by crystallography to a resolution of 2.3Å along with biochemical assays. 
So far only one approved drug for clinical use is available that directly blocks the leukotriene 
biosynthesis, Zileuton™, whereas other drugs block receptors for leukotrienes. One reason for the 
lack of inhibitors may be the lack of detailed knowledge of the first steps in the leukotriene 
biosynthesis, something this thesis project initially set out to clarify.  
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1 INTRODUCTION & BACKGROUND 
The human body works by several biochemical processes which control numerous 
pathways [1]. Various triggers can activate these pathways which leads to different 
biological responses [2]. Inflammation is one such response exerted by the human body 
upon interaction with harmful stimuli as a protective step to deter further interaction, 
damage and initiate the healing process [3]. In a nutshell, inflammation is an initial immune 
response and its function is to segregate, destroy and remove the damaged tissues (along 
with stimuli) by the interaction with harmful stimuli and restore the normal tissue function 
[4]. This immune response can be classified as acute and chronic inflammation [5].  
Acute inflammation occurs within minutes on interaction with stimuli such as microbial 
infection. This infection triggers the releases of vasodilators by mast cells to increase the 
permeability of the blood vessels [6]. This aids the movement of immune cells like 
neutrophils to reach the interaction site through the capillary wall to neutralize the harmful 
stimuli [7]. Acute inflammation subsides on reducing/avoiding the interaction with the 
harmful stimuli. 
The chronic inflammatory response is characterized by prolonged inflammation usually 
from weeks to months to lifelong. Chronic inflammation is transitioned from acute 
inflammation and its several characters are mentioned in Table 1. Acute inflammation 
initiates tissue repair process and in the case of chronic inflammation, this becomes 
chronically engaged leading to prominent structural distortion of the affected tissue [8]. 
This is mainly caused by persistent interaction with harmful stimuli or by auto-immune 
diseases, where the inflammation is triggered by the host [9]. During chronic inflammation, 
tissue repair and destruction takes place simultaneously. 
Feature Acute Chronic 
Onset Rapid: in minutes or hours Delayed: Days 
Cellular infiltrate Mainly neutrophils Monocytes/macrophages 
and lymphocytes 
Tissue injury, fibrosis Usually mild and self- 
limited 
Often severe and 
progressive 
Local and systemic signs Prominent Less prominent to very 
prominent 
 
Table 1: Features of acute and chronic inflammation [10] 
 8 
There are several biochemical pathways involved in inflammation [3]. Leukotrienes (LTs) 
are one of the significant lipid mediators of leukocyte accumulation in acute inflammation 
[11] and also in chronic inflammatory diseases like asthma [12], allergic rhinitis [13] and 
rheumatoid arthritis [14]. 
1.1 LEUKOTRIENE BIOSYNTHESIS 
Arachidonic acid (AA) is a polyunsaturated fatty acid of 20 carbons and is the precursor of 
LTs. It is an integral component of the biological membrane in the resting cell [15]. LT 
biosynthesis requires different proteins (Figure 1) to work in sequence, the first one being 
cytosolic phospholipase A2 (cPLA2) [16]. Upon stimulation, intracellular Ca
2+
 concentration 
increases which leads to movement of cPLA2 from the cytosol to the nuclear membranes. 
There is also a slight structural change of cPLA2 which increases its binding affinity towards 
phospholipids and hydrolyses the ester bond in the sn-2 position of phospholipids releasing 
the arachidonic acid [17].  
Next coming into play in this concert is a protein called 5 lipoxygenase (5LO). The 
hypothesis is that the AA is now presented to 5LO by an integral membrane protein called 5-
lipoxygenase activating protein (FLAP). The exact mechanism of and extent of involvement 
of FLAP are still not clear. AA is converted to 5(S)-hydroperoxyeicosatetraenoic acid (5(S)-
HPETE) and then to Leukotriene A4 (LTA4) by 5LO. The LTA4, the first leukotriene made, 
will be converted to Leukotriene B4 (LTB4) by Leukotriene A4 hydrolase (LTA4H) or 
Leukotriene C4 (LTC4) by Leukotriene C4 synthase (LTC4S) [18].   
 
Figure 1: Initial stages in leukotriene biosynthesis 
LTC4 is converted to Leukotriene D4 (LTD4) by γ-glutamyl leukotrienase [19]. LTD4 is 
converted to Leukotriene E4 (LTE4) by a membrane-bound dipeptidase by removing glycine 
[20]. These later leukotrienes C4, D4, and E4 are termed “cysteinyl LTs” (cysLTs).   
Higher levels of expression of 5LO and FLAP are seen in leukocytes [21]. A higher level of 
production of LTB4 is seen specifically in neutrophils [22]. Cysteinyl LTs product levels are 
more pronounced in of eosinophils, mast cells, and basophils [23]. Macrophages and 
dendritic cells can synthesize all type of LTs. Non-leukocyte type cells like human bronchial 
fibroblasts can synthesize lower levels both LTs due to a lesser expression of 5LO/FLAP 
[24,25]. LTs can also be synthesized remotely in a non-leukocyte cell like an endothelial cell 
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by intercellular migration of LTA4 synthesized from a leukocyte such as neutrophil, termed 
as transcellular biosynthesis [26]. Synthesized LTs are exported to the extracellular space by 
ABC transporters [27] and interact with specific G protein-coupled receptors that are situated 
on the outer plasma membrane of other cells [28]. 
 
Cell Type 
 
BLT1 
Receptors 
CysLT1 
 
CysLT2 
Neutrophil  + ± ± 
Macrophage or monocyte  + + + 
Dendritic cell  + + ? 
Eosinophil  + + + 
Basophil  + + + 
Mast cell  + + + 
B cell  ? + ? 
CD4
+
 T cell  + + ? 
CD8
+
 T cell  + ? ? 
Hematopoietic progenitor cell  ? + ? 
Epithelial cell  ? + + 
Airway smooth muscle cell  + + ? 
Fibroblast  + + ? 
Fibrocyte  ? + + 
Endothelial cell  + + + 
Receptor expression: positive (+), negative (−), minimal (±) or as yet undetermined (?) 
Table 2 : Table for receptors in leukotriene biosynthesis [29] 
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Several receptors (Table 2) are involved in LT pathway and there are drugs (Table 3) 
available in market against different targets in leukotriene biosynthesis. 
Target Drugs 
5LO Zileuton [30] 
BLT 
U75302 [31], LY255283 [32] 
CP-105696[33] 
Cys LT1 Montelukast [34], 
Zafirlukast[35], Pranlukast 
[36] 
Cys LT2 BAY u9773[37,38]  
 
Table 3: Anti-leukotriene drugs 
1.2 COMPONENTS OF LEUKOTRIENE BIOSYNTHESIS 
1.2.1 5-Lipoxygenase 
5LO is a 78 kDa mobile protein (Figure 1 and Figure 2) and it catalyzes the conversion of AA 
to LTA4. The structure of 5LO (PDB ID: 3O8Y) was published in 2011 [39]. It consist of a 
large C-terminal catalytic subunit composed of α-helices and contains a non-heme iron. A 
small N-terminal c2-like regulatory subunit constitutes a β sandwich. This regulatory domain 
of 5LO contains loops with the residues tryptophan 13, 75 and 102 involved in anchoring the 
5LO to the membrane [40,41]. The rise in intracellular calcium concentration leads to binding 
of Ca
2+
 to the c2-like regulatory domain, which makes the enzyme to move from the cytosol 
to nuclear membrane. After binding to the nuclear membrane, 5LO binds with AA. This is 
followed by abstraction of pro-S hydrogen H7 from C7 of AA  and O2 is introduced at C5 to 
form 5(S)-HPETE. The next is the formation of an unstable epoxide called LTA4 by the 
abstraction of pro-R hydrogen H10 (from C10 position) causing dehydration of 5(S)-HPETE 
[42]. The active form of 5LO is a monomer and the existence of a dimeric form of 5LO was 
reported in 2011 [43]. Dimerization of 5LO was shown to occur by the formation of 
intermolecular disulfide bridges between cysteines C159, C300, C416 and C418 of the 
monomers leading to the dimerization. Bridges between these cysteines would lead to 
assembly in a head to tail orientation that would cover the catalytic iron binding site first 
shown 2011 [43] and later proved in cells 2015 [44]. This orientation of dimeric 5LO might 
hinder the substrate access portal leading to reduced production of LTA4. The dimeric 5LO 
lacks enzymatic activity and cannot bind to a membrane in vitro [45]. 
 There are several factors which can activate and aid the enzymatic activity of 5LO [46]. 5LO 
can bind to calcium and it is reversible. Kd for calcium is 6µM and two Ca
2+
 can bind to 
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specific tryptophans on 5LO in the membrane binding process [40,41,47]. Similar to 5LO, 
cPLA2 contains a c2 like domain which binds to the membrane through tryptophans when 
these are bound to calcium. The release of AA from the membrane by cPLA2 could be 
regulating the efficient utilization of 5LO [48]. In vitro studies indicate that membrane plays 
a major role in the regulation of the activity of 5LO. Cationic lipids are stimulatory and 
negatively charged lipids proved to inhibit the activity of 5LO [40]. The preferential binding 
of 5LO to the membrane is regulated by membrane fluidity rather than the composition of the 
lipids in the membrane. Membrane fluidity is increased by the presence of unsaturated bonds 
and in the case of 5LO, lipids with a high number of cis unsaturated bonds in the sn-2 acyl 
chain like the oleoyl in POPC or arachidonoyl in PAPC has shown to improve the activity of 
5LO [46].  Coactosin-like protein (CLP) is a small 16 kDa F-actin binding protein that can 
bind to 5LO and the association increases the activity of 5LO in the absence of 
phosphatidylcholine (PC) and also it promotes the formation of LTA4 in the presence of PC 
[49]. 
 
Figure 2: 5LO Mechanism for the formation of LTA4 from AA via the intermediate 
5(S)-HPETE. The proteins involved in each step are indicated. 
Magnesium can stimulate the activity of 5LO in vitro with a Kd in mM range [50]. Even 
though ATP can bind to 5LO [51], it does not have any effect on its activity by itself. 
However, coupled with calcium, ATP has shown to improve the activity of 5LO [52]. In 
living cells, magnesium forms a complex with ATP as MgATP
2+
 which is an activator of 
5LO and could replace ATP [50]. The activity of 5LO is also regulated by phosphorylation at 
different sites [48]. Certain  phosphorylation upregulates the activity of 5LO, other down 
regulate the activity and some affect localisation [53].  Phosphorylation at Serine 523 is 
regulated by protein kinase A (PKA). This phosphorylation has been reported to prevent 
nuclear localization and to reduce product formation in both in vitro and in vivo [54,55,56]. 
Phosphorylation on Serine 271 and 663 upregulates the enzymatic activity and the 
translocation of 5LO to the membrane. The former one is regulated by p38 kinase-dependent 
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MAPKAP kinases [57,58] and the later one by an extracellular signal-regulated kinase 2-
dependent kinase (ERK2) [53,59]. 
 
Figure 3: Enzymes involved in leukotriene biosynthesis 
1.2.2 FLAP 
Five Lipoxygenase Activating Protein (FLAP) is an integral membrane protein that belongs 
to the Membrane Associated Proteins in Eicosanoid and Glutathione metabolism (MAPEG) 
superfamily [60,61]. It was identified as a 18 kDa protein bound to MK886 in a photoaffinity 
analysis [62]. The crystal structure of FLAP (PDB ID: 2Q7R) was solved and published in 
2007 [63] to 4.2 Å (Figure 1 and 3).  FLAP can bind to arachidonic acid [64].  The exact role 
of FLAP is still not clear. It is hypothesized to facilitate efficient transfer of AA to 5LO along 
with the conversion of 5(S)-HPETE to LTA4 [65]. FLAP may also play a regulatory role by 
facilitating an initial supple complex formation with 5LO for efficient product formation and 
in a later stage, the complex becomes rigid leading to termination of activity of 5LO [66]. 
CLP forms a stable complex with 5LO which conserves the activity of 5LO [67]. This 
complex then moves from cytosol to the nuclear membranes where the complex anchors near 
FLAP which stabilizes the whole complex and facilitates the product formation [68]. 
1.2.3 Leukotriene C4 Synthase 
LTC4S (Figure 1 and 3) is a homotrimeric integral membrane protein comprising 12 
transmembrane α-helices [69]. It also belongs to MAPEG family [61]. The structure (PDB 
ID: 2UUH) was determined in 2007. It resides in the outer nuclear membrane and ER with 
the catalytic site facing the cytosol located in the interface between the monomers as is the 
case for all MAPEG trimers [70]. LTC4S catalyses the conversion of LTA4 to LTC4 by the 
addition of glutathione [71]. This LTC4 is exported extracellularly through multidrug 
resistance protein-1 (MRP-1) [72]. 
1.2.4 Leukotriene A4 Hydrolase 
As a bifunctional enzyme, human LTA4H (Figure 1 and 3), has epoxide hydrolase activity 
which converts LTA4 to LTB4 , a potent inflammatory mediator and also an aminopeptidase 
activity [73]. The structure of human LTA4H (PDB ID: 1HS6) was solved in 2001 [74]. As a 
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soluble enzyme with 69 kDa of molecular mass, the catalytic sites for both activities overlap 
and depend on a zinc atom [75]. The distinct feature of hLTA4H is the suicidal inactivation of 
both activities by covalent binding and modification of the substrate LTA4 with tyrosine at 
378 [76].  
1.3 SPECIFICITY OF ENZYMES 
Enzymes catalyze the conversion of substrates into products. The specificity of the enzyme 
makes the catalysis very efficient. Specificity of an enzyme can be categorized as in Chart 1. 
 
Chart 1: Different type of enzyme specificities [1]   
Enzymes possessing absolute specificity can convert only one type of substrate (e. g. Lactase-
Lactose). In the case of relative specificity, the enzyme can act on reactants belonging to a 
family of closely related substances (e.g. alcohol dehydrogenase - different alcohols).  Group 
specificity is exhibited by an enzyme specific towards certain bond or certain chemical group 
(e.g. Trypsin-Amino group of lysine, arginine and histidine). Optical or stereo-specificity are 
characteristic of enzymes specific for a substrate with a specific optical configuration (e.g. α-
amylase – α glycosidic bonds in starch). 
An isomer is a molecule which possesses same chemical formula with a different chemical 
structure. In atomic terms, both molecules have the same atomic composition but differ in the 
spatial arrangement of atoms. Isomers can be classified as structural isomers and 
stereoisomers. Structural isomeric molecules are characterized by attachment of functional 
groups and atoms in different ways. In the case of stereoisomers the geometrical position of 
atoms and the functional group is different for the same molecule. 
1.3.1 Lipoxygenases 
Lipoxygenases are a class of enzymes which catalyze the peroxidation of polyunsaturated 
fatty acids. The products produced by the six human lipoxygenases are all stereo-regio 
specific [77]. The substrate AA has three sites for hydrogen abstraction and the products 
produced are either R or S isomeric state.  Peroxidation of AA can be catalyzed by both 5 and 
15 lipoxygenases and produces the corresponding S- isomeric peroxide [78] due to two 
different binding orientation of AA, either the carboxyl group enters first or the hydrocarbon 
enters first into the active site [79,80].  
Enzyme 
specificity 
Absolute 
specificity 
Relative 
specificity 
Group 
specificity 
Optical or stereo 
specificity 
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The 5LO is different from other lipoxygenases like 15LO, 12LO and 8RLO in several ways. 
First one is the ability of 5LO to convert 5(S)-HPETE into LTA4 which is not seen in any 
other lipoxygenase both in vivo and in vitro [81]. This conversion of HPETE to LTA4 is also 
seen in 15LO which can convert 15HPETE into 14, 15-leukotriene A4, but it is only seen in 
vitro [82]. Other lipoxygenases do not require auxiliary proteins like FLAP [66,68] and CLP 
[68] to perform the catalysis efficiently as in the case for 5LO. The structure of 5LO 
published in 2011 [39] indicated the catalytic site of 5LO is completely enclosed which is 
distinct from other lipoxygenases [39]. The U-shaped active site is completely accessible in 
other lipoxygenase but in the case of 5LO (also Baltic coral 11RLO) the α-helix 2 is broken 
and becomes inaccessible due to the closure by aromatic amino acids [39,83].  
1.3.2 Hydrolase 
Whereas LTA4H from human catalyses the conversion of LTA4 to LTB4, LTA4H from 
Xenopus laevis (xlLTA4H) can form two products (Figure 4) LTB4 and Δ
6
-trans-Δ8-cis LTB4 
[84]. This new product is able to bind to the BLT1 receptor (see section 1.1 and Table 2) to a 
certain extent and can cause muscle contraction [85]. The crystal structure of xlLTA4H was 
solved in 2014 [84].  
 
Figure 4: LTA4H mechanism showing the two products formed, catalyzed by the 
leukotriene hydrolase from Xenopus laevis.  
From the solved structure, it was evident that the catalytic site is too narrow to form both 
products. Triene C4-C13 of LTA4 is very flexible and it is altered during the catalysis. This 
leads to conformers of LTA4. Conformers arise due to conformational isomerism where the 
isomers are formed due to rotations about the single bonds. From the crystal structure and 
conformer analysis in silico, it was suggested how the two products are formed by xlLTA4H. 
The product formed depends on the conformational isomeric state of the substrate when it 
binds to the active site. Another reason could be phenylalanine 375 which reduces the 
substrate specificity of xlLTA4H. The human LTA4H cannot produce the second product, 
since the phenylalanine is replaced by tyrosine thus making the catalysis more specific. 
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1.4 CELLS  
As the name signifies, leukotrienes are expressed in leukocytes [86]. These are white blood 
cells whose function is to defend the organism from infectious diseases and external agents 
[87]. Leukocytes are produced in hematopoietic stem cells in the bone marrow and these are 
present in all parts of the body [88]. They are broadly classified into five different types 
namely neutrophils, eosinophils, basophils, monocytes and lymphocytes. These leukocytes 
are mobile, seen in the blood and lymphatic system which is circulated throughout the body 
[89].    
1.5 MEMBRANES & MEMBRANE MIMETICS 
In above mentioned cell types and in any cell in general, membranes and membrane proteins 
play roles directly or indirectly in any given biochemical pathway to perform the function of 
the particular cell type [90]. They also play vital roles as structural support, in the selective 
passage of molecules, in signalling to initiate certain biochemical pathways etc [91]. In fact, 
leukotrienes are transferred across the cell membrane by transporters [72] to reach its 
corresponding receptor [92].  
Membranes are bilayers made of two leaflets of lipids. The function of a given membrane is 
determined by the proteins embedded in the membrane and its lipids composition [93]. 
Phospholipids, glycolipids and sterols are examples of lipid classes with very different 
characteristics and structures (Fig. 5). The majority of bilayers contain a high concentration 
of phosphatidylcholine, a type of phospholipid carrying the zwitterionic headgroup choline 
[94] and more or less saturated acyl chains of varying lengths.  
Sterols are mainly present in animal cells, e. g. cholesterol which confers membrane rigidity 
by promoting stiffer packing of phospholipid acyl chains. Glycolipids are normally located 
on the plasma membrane surface of the cell and functions as cell surface markers. They are 
made of various carbohydrate sugar chains. 
 
Figure 5: Different type of lipids 
There are two ways to study the function of isolated membrane associated proteins (MAPs). 
The first one being isolation from the native membrane source directly. Such a methodology 
provides the most native form of the membrane and MAPs. Difficulties arise in identifying 
the native source that would provide amounts large enough to perform several experiments 
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and to purify the MAP to high concentration. An alternative method is to use membrane 
substitute systems to mimic membrane and furthermore that the proteins can be expressed by 
a recombinant expression system which would provide sufficient a quantity of protein. 
Relative ease in purification from recombinant sources is often found. However, the original 
membrane source of a MAP may require some extra consideration as to the choice of 
expression host and later in the choice of lipid mimetics. Selection of recombinant expression 
host depends on several biochemical characteristics of the protein of interest [95].  
1.5.1 Detergent micelles 
Detergents are amphipathic molecules similar to lipids but contain one hydrophobic tail and a 
hydrophilic head which makes their aggregation in water different from that of lipids 
described below (Section 1.5.2). When the concentration of detergent in a given system 
increases above certain concentration called critical micellar concentration [96], micelles are 
formed spontaneously. The micelles (Figure 6) are formed in a way that the hydrophilic 
region interacts with water and the hydrophobic tails, facing and covering the hydrophobic 
regions of the protein and forms a protein detergent complex. They are used for 
solubilisation/isolation of membranes and in purification of membrane proteins [97]. 
 
Figure 6: Detergent micelles 
1.5.2 Liposomes 
Liposomes are sphere shaped vesicles of lipids. These can be of a varied size from 2.5 nm to 
2.5 µm. These can be produced by disrupting the native membrane which disrupts the 
structure even though the individual lipids maintain their character. This leads to reassembly 
into vesicles/liposomes denoted microsomes. Another method is to use the commercially 
manufactured lipids dissolved in chloroform, then dried to form a lipid cake. This cake is then 
hydrated with an aqueous solution and then agitated briefly to form liposomes [98]. Spherical 
objects like unilamellar small or giant vesicles or multilayered vesicles may form after 
sonication. Uniform vesicle sizes are obtained by extrusion of a solution of larger liposomes 
through a narrow pipe. 
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Figure 7: Liposome 
The structure of liposome (shown in Fig. 7) makes it an interesting tool to use in biological 
sciences and in the medical field [99,100]. Its application is extensively researched in drug 
delivery due to the fact that it has a separate place for both hydrophobic and polar molecules 
in one structure [101].  
1.5.3 Nanodiscs 
Nanodiscs are assembled from two molecules of membrane scaffolding protein (MSP) 
enclosing phospholipids. The lipid molecules are non-covalently assembled like a bilayer and 
two molecules of MSP wrap around the hydrophobic lipid acyl chains in a belt like manner 
forming a nanodisc. 
Figure 8: A nanodisc. Lipid core in orange. The two MSP proteins are coloured in light 
and dark blue. [102] 
The MSPs are engineered versions of apolipoprotein-A1 and are made of 11-mer or 22-mer 
α-helical repeats punctuated with glycine or proline.  The number of helical repeats 
determines the length of MSPs, hence the diameter of the nanodisc (10-20) [103]. As the 
MSPs have a soluble conformation in the absence of lipids, the nanodiscs were made by 
mixing MSPs and detergent-solubilized lipids in a defined ratio. This is followed by 
removing the detergent using bio-beads, upon which the MSP spontaneously rearranges with 
lipids to form nanodiscs [103]. The nanodiscs can be made as an empty nanodisc, i.e. 
containing only lipids encircled by the two MSPs, for use to mimic plain membrane. 5LO 
binding on a POPC bilayer is one example of this application (paper I and II). MSP and lipids 
can also self-assemble with a transmembrane protein, the most common use of the nanodisc 
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membrane mimic so far [102]. The nanodiscs are planar, both surfaces are accessible, are 
defined in size due to the choice of MSP length and can be quantified using the UV280 nm 
absorbance of MSP which makes them a better membrane substitute in certain cases. Another 
more interesting feature is the option of selecting different MSPs (see Table 4) depending on 
the application and target. Is a membrane area around the transmembrane protein necessary 
for some reason? In this case, the nanodisc could be a good mimetic as the membrane area 
could have a predefined size that would allow precisely one interaction partner to bind both 
the transmembrane protein and embed on the membrane area. Such reconstituted membrane 
proteins in nanodiscs can be subjected to regular biophysical, enzymatic or structural 
experiments [104].   
Here, the MSP denoted MSP1E3D1 was reconstituted with POPC to form a disc with an 
outer diameter of around 12 nm. This was used to investigate the membrane binding property 
of 5LO which is around 10 nm in length. 
 
 
 
 
 
 
 
 
Table 4: Different MSPs and resulting nanodisc diameter [105] 
 
 
 
 
 
 
 
 
 
MSP Disc diameter (nm) 
MSP1D1dH5 8.2 (+/- 0.6) 
MSP1D1 9.5 (+/- 1.1) 
MSP1E3D1 12 (+/-1) 
MSP2N2 16 (+/-1) 
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2 AIM 
The main aim of the thesis is to understand the mechanisms involved in leukotriene 
biosynthesis using several methods.  
Papers I - III: Papers I - III: The crucial step in leukotriene biosynthesis is calcium-mediated 
binding of 5LO to the membrane. In paper I this interaction is characterised regarding its 
significant effects on enzymatic activity using biochemical assays and visualisation by TEM. 
Paper II aims to develop a TEM based method to visualise and analyse small membrane 
binding proteins using nanodiscs as membrane mimics. Paper III analyses the molecular steps 
involved in the catalysis of arachidonic acid by kinetic isotope effect (KIE) studies.   
Paper IV: LTA4H is the first enzyme which acts on the LTA4 to form LTB4. The human 
LTA4H has a substrate induced inactivation which is not seen or reduced in lower organisms 
like Xenopus laevis. Furthermore, it forms LTB4 along with Δ
6
-trans-Δ8-cis-LTB4. This paper 
characterises the biochemical mechanism of catalysis of xlLTA4H. 
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3 MATERIALS & METHODS  
The methods used in this thesis which promoted understanding of the leukotriene 
biosynthesis are explained in detail in the “Materials and Methods” section of constituent 
papers. Briefly, some of the methods used in the paper I are described below. 
3.1.1 Purification and stabilization of 5LO 
Recombinantly expressed human 5LO loses its enzymatic activity within 10 hours after 
purification. To extend the enzymatic life span of 5LO, the following precautionary steps 
were taken. All the working buffers were extensively degassed and purged with nitrogen to 
remove oxygen. All the buffers were supplemented with 10 μ MFeSO4 and 20 μg/ml catalase 
to prevent non-turnover based inactivation of 5LO [106]. For the experiments concerning 
monomeric 5LO, all the buffers were also supplemented with TCEP, a reducing agent to 
prevent dimerization of 5LO [107]. 
3.1.2 Calcium native PAGE analysis 
The titration analysis performed in section 4.1.2 below, was done in sequential steps, the first 
one being an overnight equilibration of the native PAGE gel by a dummy run with running 
buffer containing 1 mM CaCl2 and 5 mM β-mercaptoethanol at 30 V at 4°C. The separation 
run was performed the next day at 150 V, 4°C in the Ca
2+
 equilibrated gel.  
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4 RESULTS & DISCUSSIONS 
4.1 PAPER I & II 
5LO needs only Ca
2+
 to translocate to and bind to membranes. FLAP is not required to be 
present in the membrane for this translocation. The aim of the paper I was to characterise the 
membrane binding of 5LO in the absence of FLAP and to use nanodiscs as the membrane 
mimetic. The 5LO-ND complex formation was analysed by Coomassie blue stained non-
denaturing polyacrylamide gel electrophoresis (blue native PAGE) and the enzymatic activity 
of 5LO was measured with UV-spectrometry and LC-MS/MS. The oligomeric state of 5LO 
was determined by blue native PAGE and its membrane associating capability and enzymatic 
activity was analysed by the above methods. All complexes were also analysed by negative 
stain TEM. Paper II is a continuation of Paper I. A method was developed to study membrane 
binding of peripheral membrane proteins using TEM and turning a particular negative stain 
induced artefact exerted on phospholipids into an advantage.  
4.1.1 Initial binding analysis and oligomers of 5LO 
The project started with the analysis of the interaction between 5LO and nanodiscs using blue 
native PAGE. The results showed that 5LO interacts with nanodiscs in the presence of 
calcium and a lack of binding is seen without calcium. The presence of 5LO was identified 
by excision of the band containing the complex of 5LO and nanodisc with calcium and 
running it on a denaturing PAGE followed by immunoblotting. An intriguing part of this 
experiment was the presence of a higher molecular weight band in the lane where only one 
band representing pure 5LO was expected. In 2011 Häfner et al. described the presence of 
dimerised 5LO due to inter-protein disulphide bond formation between 5LO´s cysteines, 
C159, C300, C416 and C418, located on the surface [43].  On examination of the 5LO SEC 
column eluate, showing two peaks, the former peak presented a retention volume 
corresponding to a weight twice the molecular weight of 5LO (78 kDa). The fractions were 
analysed in denaturing PAGE and immunoblot analysis which showed the presence of 5LO 
in both fractions indicating the former peak being a dimer of 5LO and the later one being the 
monomer of 5LO. The TEM analysis showed different orientations of dimeric 5LO. The 
dimer formation was prevented by using a reducing agent TCEP in all the working solution 
[45]. 
4.1.2 Analysis of monomeric 5LO 
Initial analysis of the calcium-mediated binding of 5LO with nanodiscs using blue native 
PAGE showed a positive association. A titration analysis was performed in order to learn if 
the calculated size of the nanodiscs is sufficient for binding of 5LO and if both sides of the 
nanodisc would be used for binding. In the initial analysis, the observed band was weak due 
to the absence of Ca
2+ 
in the gel which is required by 5LO for binding. Hence titration 
analysis was performed on a native PAGE equilibrated with Ca
2+
 before the separation run. 
The titration analysis of different ratios of 5LO and nanodiscs showed that a maximum of 
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two monomeric 5LO can bind to one disc. We could also see the 5LO: nanodisc complex (1:1 
ratio) in a lane where only the complex with a ratio of 2:1 was expected, leading to a 
conclusion that there could be an equilibrium in the binding events. 
The enzymatic activity of monomeric 5LO (with and without calcium) was analysed by UV-
spectrometry and LC-MS/MS, where the former one was used to measure the formation of 
5(S)-HPETE and the later one for LTA4. The data obtained indicated that association keeps 
the 5LO active and that it is comparable to previous studies with liposomes [81]. Without 
calcium, the activity of 5LO was reduced considerably, even in the presence of membrane 
environment. It was almost double in the presence of nanodiscs compared to liposomes. This 
could be due to sequestering of AA in the liposome interior, which leads to less free AA in 
the solution, whereas nanodiscs lack this kind of sequestering capacity leading to higher 
concentration of free AA in solution. 
4.1.3 Analysis of dimeric 5LO 
The dimeric 5LO did not bind to nanodiscs in the presence of calcium. This could be due to 
the head to tail dimer configuration of 5LO [43]. This configuration might mask and create a 
steric hindrance of W75 thereby preventing its association to the membrane. Furthermore, a 
lack of enzymatic activity is seen with the dimeric 5LO. There is no direct way to assign a 
lack of activity to dimerisation of 5LO since, discriminating the lack of activity between 
enzymatic inactivation [108], non-enzymatic inactivation [106] or due to oligomerisation is 
not possible. Understanding the different mechanisms of inactivation in 5LO could provide 
more information on regulation of the 5LO.  
4.1.4 A method to visualize small membrane binding proteins by TEM 
A method was developed to study small membrane interacting proteins like 5LO by TEM 
and nanodiscs. We took advantage of the aggregation phenomenon of phospholipid 
liposomes induced by a particular negative stain called sodium phosphotungstate (NaPT). 
This binding of liposomes on each other leading to so called stacking is probably due to an 
electrostatic interaction between the phospholipids and the phosphoryl group of 
phosphotungstate [109]. Since the nanodisc has a lipid bilayer core, a similar effect (Figure 
9A) was seen on staining nanodiscs with NaPT. We speculated in our hypothesis (Figure 9B) 
that since this stacking is caused by electrostatic interaction, any object which may sit in any 
of the two planar sides of the nanodisc could prevent stacking which could be concluded as a 
positive interaction with nanodiscs, in other words, the protein is interacting with a 
membrane.  
5LO which binds to nanodiscs in the presence of calcium was used to test this hypothesis. 
Several combinations - nanodiscs, nanodiscs with calcium, nanodiscs with monomeric 5LO 
without calcium, nanodiscs with monomeric 5LO with calcium, dimeric 5LO with nanodiscs, 
dimeric 5LO with nanodiscs and calcium - were analysed. As per hypothesis, monomeric 
5LO in the presence of calcium bound to nanodiscs which caused the steric hindrance leading 
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to prevention of stacking. There was no stacking visualised with the complex of monomeric 
5LO-ND with calcium, corroborating the previous results from native pages. 
 
Figure 9: Principle of stacking of nanodiscs 
Class averages obtained by TEM from the complex of 5LO-ND showed different interesting 
binding modes of monomeric 5LO with a membrane. The stacking was seen with the 
monomeric 5LO with nanodiscs without calcium showing the absence of membrane binding 
event. Another interesting result was the presence of stacking in the sample containing 
dimeric 5LO and nanodisc in the presence of calcium. Even if dimeric 5LO can bind calcium 
ions this does not promote binding to membrane which are in line with the previous native 
PAGE results. Stacking has also been seen in nanodiscs with calcium indicating that 
prevention of stacking was not induced by calcium.  
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4.2 PAPER III 
In this paper, the molecular steps leading to the formation of 5-HETE is studied in detail by 
KIE analysis. The product formation was measured by both UV-spectrometry and RP-HPLC 
using normal AA and deuterated AA. 
4.2.1 Kinetic isotopic effect studies on 5LO 
The initiation of leukotriene biosynthesis starts with 5LO oxygenating AA to form 5(S)-
HPETE followed by a dehydration step to form LTA4. The pro-S hydrogen is removed from 
C7 and O2 is inserted into C5 of AA by 5LO which forms 5(S)-HPETE. LTA4 is formed by 
removing pro-R hydrogen from C10. To understand the mechanism better, labelled 7,7-d2-
AA was compared with AA and HETEs formation was measured at 235nm.  
The substrate AA was deuterated which lowered the isotopic effect indicating a change in 
region-selectivity. Unlabelled AA produced 95% 5-HETE and 8 % 8-HETE whereas labelled 
AA produced lower 5-HETE (59%) and higher 8-HETE (41%). This shows that selectivity of 
5LO has been reduced due to deuteration of AA. The catalytic rate kcat for labelled AA (0.01 
s
-1
) was approximately seven times less than AA (0.06 s
-1
) which shows decreased deuterium 
abstraction at C7 together with higher substrate inhibition.  
Strong substrate inhibition at higher substrate concentration reduced the KIE leading to a 
conclusion that functional integrity of 5LO rather than the labelling of the substrate is in play. 
Kinetic parameters were calculated at low AA concentration leading to less a substrate 
inhibition. There is a 2 fold change in KM between the labelled and unlabelled indicating KIE 
is not affected by substrate binding at low concentration. Altogether it can be safe to infer that 
the observed KIE for the kcat/KM is from the hydrogen abstraction step. Arrhenius plot 
analysis shows a possibility of tunnelling during hydrogen transfer step.  
Analysing the structure of 5LO reveals that larger residues like F421, Q363 and L368  might 
interfere in the AA rearrangement during the catalysis leading to lower reaction rate and also 
reduces the substrate selectivity leading to the formation of 8-HETE (in the case of labelled 
AA). 
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4.3 PAPER IV 
The aim of this paper IV was to provide a structure based explanation for the different 
mechanisms of product formation by the Xenopus laevis LTA4 hydrolase compared to the 
human LTA4 hydrolase (see section 1.2.4 and 1.3.2). The mechanism of product formation by 
xlLTA4H was studied by spectrometry, RP-HPLC and in silico conformer analysis and the 
structure was solved by X-ray crystallography and SAXS. 
4.3.1 Activity assay 
The mutant F375Y cannot produce the second product Δ6-trans-Δ8-cis-LTB4 and the catalytic 
activity of xlLTA4H is 20 times higher than human. KM for wt xlLTA4H 45 µM is higher 
than KM for mutant which is 4 µM, this indicates the phenylalanine´s role in binding and 
recognition of the LTA4. Substrate selectivity of xlLTA4H is likely reduced in wildtype due 
to rapid turnover rate. All the evidence indicates that LTA4 binds to Y378 in hLTA4H during 
catalysis which leads to suicidal inactivation. 
With the methyl ester of LTA4 (LTA4-ME), the epoxide hydrolase activity is reduced by 20% 
in wild type and to 80% in mutant F375Y. In the case of aminopeptidase activity, wild type 
showed 15% reduction in activity and the mutant showed 90% reduction. The fact the activity 
is reduced in wild type enzyme can be reasoned with earlier studies on human LTA4H, 
showed the covalent interaction between Tyr 383 and LTA4. Testing the wild type and 
mutant for the second product Δ6-trans-Δ8-cis-LTB4, indicated that the mutant cannot 
produce any Δ6-trans-Δ8-cis-LTB4 and wild type produced Δ6-trans-Δ8-cis-LTB4 and LTB4 
in the ratio of 1:10. The wild type also produced 5(S), 6-DHETE and 5(S), 12 DHETE.  
4.3.2 Crystallization of xlLTA4H 
Limited proteolysis yielded crystals which were used to solve the crystal structure of the 
xlLTA4H to 2.3Å. The crystal structure revealed a three domain architecture with the active 
site in the interface between domains. The striking difference between the human and 
Xenopus enzyme is the change in residue from tyrosine to phenylalanine at 375. The crystal 
structure revealed that the active site is narrow for LTA4 and will cause steric hindrance to 
form the second product Δ6-trans-Δ8-cis-LTB4, which requires propeller like movement of 
LTA4 chains. LTA4 cannot change the conformation inside the active site to form the second 
product.  
4.3.3 Conformer analysis 
The conformer analysis of LTA4 revealed that 87% of LTA4 population in a given system is 
in S-trans configuration and 6.4% as trans-cis-trans, leading to a conclusion that the former 
produces LTB4 and the later one produces Δ6-trans-Δ8-cis-LTB4. All data indicates that 
LTA4H from Xenopus laevis produces the second product due to the presence of the 
conformer already in the solution or it is formed during the entrance of the active site. The 
phenylalanine at position 375 is less sensitive to the small change in substrate LTA4 and 
LTA4 conformers which may lead to dual product formation in lower organisms.  
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5 CONCLUSION & FUTURE WORKS 
Membrane proteins are notoriously difficult to handle due to their dual nature having both 
hydrophobic and hydrophilic surfaces. Recent developments in the field of 
membrane/associated protein handling like amphipols [110], SMALPS [111] and Salipro 
[112] led to the understanding of proteins through biochemical and biophysical analysis or by 
structure determination which was not possible before. One of the successful platforms, the 
nanodisc, makes it possible to provide close to in vivo environment in vitro [105].  Nanodiscs 
have been used as membrane mimics to study the enzymatic activity of  15LO [113].  
Nanodiscs were used in this thesis instead of other membrane mimics for the following 
reasons. Detergent micelles would not provide the crucial biological support provided by the 
lipid membrane surface we needed for the project at hand (5LO does not need FLAP to be 
present for binding on a membrane surface, only calcium-ions [48,114,115]). Liposomes are 
better membrane mimics than detergent. Nevertheless, it would be very difficult to visualize 
the same sample of a protein-membrane-complex by both native PAGE and TEM which 
were mainly used in this thesis [45,116]. Liposomes can be made of a small size, however, 
the curvature increases which may be a disadvantage. The advantage of the nanodisc was the 
size which was carefully chosen.  
The nanodiscs used in this thesis were made from MSP1E3D1 that would provide an inner 
bilayer diameter of 10.5 nm which is an area sufficient for binding one 5LO, an almost 
cylinder shaped protein with a size of 4.5 nm diameter and 9 nm in length [40]. This size of a 
disc would also allow the inclusion of one FLAP which is about 4 nm in diameter for the 
make of a complex with one 5LO and one FLAP. Even though nanodiscs have several 
advantages mentioned earlier (section 1.5.3), there are some drawbacks like desorption of 
lipids which would be an issue, being 20 times faster than for liposomes, and should be 
considered [117]. However, this thesis illustrates nanodisc bilayers has a similar effect as the 
liposomes in activation of 5LO and showing similar product profile. 
Leukotriene biosynthesis starts with the catalytic action of 5LO [48]. Monomeric 5LO is the 
active form and binds to the membrane surface of nanodiscs in a productive manner in terms 
of product formation [45]. As mentioned earlier (the above paragraph and in section 1.3.1), 
5LO requires another protein called FLAP for efficient catalysis. That the integral membrane 
protein FLAP and 5LO interact physically has been indicated by several studies in vivo 
[68,118,119].  But how this interaction occurs at the membrane is still unknown, how the 
presentation of AA to 5LO by FLAP is made and how the activation of 5LO by FLAP occurs 
are also unknown. Reconstituting FLAP into nanodiscs and analysing its interaction with 
5LO through biochemical and structural studies would decipher this interaction. The results 
would be of importance in understanding the leukotriene pathway and also in the 
development of new drugs targeting this pathway. 
Dimerization of lipoxygenases is caused by several reasons; ligand induces the formation of 
dimeric 12/15LO [120], dimerization of 12/15LO is due to high salt and higher protein 
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concentration [121], oligomerization of 11RLO is calcium dependent [122]. Dimerization of 
5LO has been reported in 2011 [43,45]. Formation of dimeric 5LO is an interesting 
phenomenon which could be a regulating mechanism to inactivate 5LO in cells. Even though 
our work corroborates previous works on dimeric 5LO, lack of activity is still not clear. 
Analyzing the enzymatic activity of dimeric 5LO in cells is the crucial path in understanding 
the existence of a dimer in the bigger picture of leukotriene biosynthesis.  
The endonuclease denoted dicer is a ribonuclease III enzyme involved in the production of 
microRNAs (miRNAs). It is a multi-domain enzyme and the C-terminus of human dicer has 
been shown to interact with 5LO through yeast two hybrid system [123]. The molecular 
details of this interaction would provide a possible role of 5LO in other pathways.  
The role of phenylalanine is crucial in LTA4H in Xenopus laevis and is less discriminative on 
its conformers of the substrates [84]. Analysing the distribution of conformers and altering its 
distribution may have a profound effect on the activity of LTA4H. Studying this effect could 
lead to effectively design drugs against LTA4H. 
The TEM method to visualize small membrane binding proteins can also be used to 
investigate an interaction between a soluble protein and transmembrane proteins reconstituted 
into nanodiscs, that is, if the transmembrane protein does not have large extra membranous 
domains. The simple protocol provides a recipe for the preparation of large quantities of 
empty nanodiscs which can be used to screen for conditions which could promote peripheral 
membrane protein binding. In fact, it could be used to screen for conditions where a drug 
candidate prevents the peripheral protein binding visualized as massive stacking of the 
nanodiscs used.  
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